SCHEMBL3470934

SCHEMBL3470934

Cc1c(C#N)cccc1N1CCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 4/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
AR P10275 1/20 0.47
NOTUM Q6P988 1/20 0.43
TSHR P16473 2/20 0.42
ALOX15 P16050 2/20 0.42
CASP1 P29466 2/20 0.42
CASP7 P55210 2/20 0.42
ADRB1 P08588 1/20 0.42
POLB P06746 2/20 0.40
MAPT P10636 2/20 0.40
ROCK2 O75116 1/20 0.40
ROCK1 Q13464 1/20 0.40
CDC42BPB Q9Y5S2 1/20 0.40
DRD4 P21917 3/20 0.40
DRD2 P14416 2/20 0.40
DRD3 P35462 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15518463 0.96 ALDH1A1 (0.51) ALDH1A1KDM4EL3MBTL1ARNOTUM
SCHEMBL27966123 0.95 ALDH1A1 (0.50) ALDH1A1KDM4EL3MBTL1ARNOTUM
Hydrochloric Acid SCHEMBL27634037 0.83 ADRB1 (0.61) ALDH1A1KDM4EADRB1MAPTDRD2
SCHEMBL30406641 0.83 AR (0.59) ALDH1A1KDM4EL3MBTL1ARPOLB
SCHEMBL2785503 0.82 DRD4 (0.46) ALDH1A1KDM4EDRD4DRD2DRD3
SCHEMBL2783360 0.80 DRD2 (0.54) ALDH1A1DRD4DRD2DRD3HTR2A
SCHEMBL829177 0.79 AR (0.65) ALDH1A1KDM4EL3MBTL1ARPOLB
SCHEMBL1878340 0.78 ALDH1A1 (0.69) ALDH1A1KDM4EL3MBTL1ARNOTUM
SCHEMBL2783971 0.78 CYP1A2 (0.47) ALDH1A1KDM4ECASP1CASP7MAPT
SCHEMBL7528396 0.77 AR (0.62) ALDH1A1KDM4EL3MBTL1ARPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014019186-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2014-02-06 WO disclosed
WO-2010071750-A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2010-06-24 WO disclosed
CN-101291912-A Pyrazole derivatives, compositions containing such compounds and methods of use MERCK & CO INC (US) 2008-10-22 CN disclosed
EP-1960392-A2 HETEROCYCLE-SUBSTITUTED 3-ALKYL AZETIDINE DERIVATIVES Merck & Co., Inc. (US) 2008-08-27 EP disclosed
CN-101238132-A Spirochroman-4-ones as acetyl-CoA carboxylase (ACC) inhibitors MERCK & CO INC (US) 2008-08-06 CN disclosed
WO-2007064566-A2 HETEROCYCLE-SUBSTITUTED 3-ALKYL AZETIDINE DERIVATIVES MERCK & CO., INC. (US) 2007-06-07 WO disclosed
CN-1964947-A Pyrazole derivatives, compositions containing the same and methods of use thereof MERCK & CO INC (US) 2007-05-16 CN disclosed